somatropin
Accretropin	Pharmaceutical company: Cangene Corporation www.cangene.com

NEW INDICATION & DOSAGE
Growth failure in children caused by inadequate secretion of endogenous growth hormone--
Children: 0.18 to 0.3 mg/kg subcutaneously each week, divided into equal doses given 6 to 7 times a week.
Short stature associated with Turner Syndrome in children whose epiphyses have not closed--
Children: 0.36 mg/kg subcutaneously each week, divided into equal doses given 6 to 7 times a week.

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins